Oncology Times (@oncologytimes) 's Twitter Profile
Oncology Times

@oncologytimes

Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology

ID: 19495715

linkhttp://oncology-times.com calendar_today25-01-2009 17:22:19

30,30K Tweet

53,53K Followers

8,8K Following

Oncology Times (@oncologytimes) 's Twitter Profile Photo

July is #Sarcoma and #BoneCancerAwarenessMonth. Stay informed by reading the latest research and expert commentary from #OncologyTimes. ow.ly/ao2u50WnJbt

July is #Sarcoma and #BoneCancerAwarenessMonth. Stay informed by reading the latest research and expert commentary from #OncologyTimes. ow.ly/ao2u50WnJbt
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Christopher Kane, MD, CEO of the UC San Diego Health Physician Group and Senior Assistant Vice Chancellor of Clinical Affairs for UC San Diego Health Sciences, was appointed President of the American Board of Urology. ow.ly/pZav50Wkspb #Oncology

Christopher Kane, MD, CEO of the UC San Diego Health Physician Group and Senior Assistant Vice Chancellor of Clinical Affairs for UC San Diego Health Sciences, was appointed President of the American Board of Urology. ow.ly/pZav50Wkspb #Oncology
Oncology Times (@oncologytimes) 's Twitter Profile Photo

#ChatGPT may help answer questions about general information on #ColonCancer, such as symptoms, screening, and prevention, but may not be up to date about #diagnosis and #treatment, according to a new study. ow.ly/PoG250WnIvi #AI

#ChatGPT may help answer questions about general information on #ColonCancer, such as symptoms, screening, and prevention, but may not be up to date about #diagnosis and #treatment, according to a new study. ow.ly/PoG250WnIvi #AI
Oncology Times (@oncologytimes) 's Twitter Profile Photo

New findings emphasize the necessity of coordinated, long-term follow-up care to address the physical, psychological, and social impacts of #survivorship for bone cancer survivors. Read more here: ow.ly/tghU50WnI5x #CancerReseach

New findings emphasize the necessity of coordinated, long-term follow-up care to address the physical, psychological, and social impacts of #survivorship for bone cancer survivors. Read more here: ow.ly/tghU50WnI5x #CancerReseach
Oncology Times (@oncologytimes) 's Twitter Profile Photo

In this episode of OncTimes Talk, we chat with Sami Mansfield, ACSM-CET, PN1, the founder of #CancerWellnessforLife, an organization dedicated to developing, implementing, and optimizing #exerciseoncology and #lifestylemedicine programs. ow.ly/m4lv50WsQRP

In this episode of OncTimes Talk, we chat with Sami Mansfield, ACSM-CET, PN1, the founder of #CancerWellnessforLife, an organization dedicated to developing, implementing, and optimizing #exerciseoncology and #lifestylemedicine programs. ow.ly/m4lv50WsQRP
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Emerging evidence shows that while CAR-T therapy offers groundbreaking benefits for hematologic cancers, it may carry a small but real risk of #SecondPrimaryCancers. ow.ly/JfB850WnRJE #CARTtherapy #CancerResearch

Emerging evidence shows that while CAR-T therapy offers groundbreaking benefits for hematologic cancers, it may carry a small but real risk of #SecondPrimaryCancers. ow.ly/JfB850WnRJE #CARTtherapy #CancerResearch
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Looking to connect with #OncologyTimes? Follow us on LinkedIn for the latest in oncology news, research, and expert insights. linkedin.com/company/oncolo…

Looking to connect with #OncologyTimes? Follow us on LinkedIn for the latest in oncology news, research, and expert insights. linkedin.com/company/oncolo…
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Oncology Times interviewed Sami Mansfield, ACSM-CET, PN1, the founder of Cancer Wellness for Life. She discussed the importance of teaching #cancerpatients and #cancersurvivors who to not only survive, but to thrive. Listen to the #podcast here: ow.ly/NkiQ50WtBab

Oncology Times (@oncologytimes) 's Twitter Profile Photo

In episode three of the OncoExTra® podcast series, Ruchika Talwar, MD, speaks with Christy Russell, MD, VP of Medical Affairs at Exact Sciences, about what oncologists can expect when they receive OncoExTra comprehensive genomic profiling test results. focusononcology.com/actionable-the…

In episode three of the OncoExTra® podcast series, Ruchika Talwar, MD, speaks with Christy Russell, MD, VP of Medical Affairs at <a href="/ExactSciences/">Exact Sciences</a>, about what oncologists can expect when they receive OncoExTra comprehensive genomic profiling test results. focusononcology.com/actionable-the…
Oncology Times (@oncologytimes) 's Twitter Profile Photo

It's #RecognizingResidents Week! At Oncology Times, we celebrate the dedication and brilliance of #OncologyResidents who are shaping the future of cancer care. Your commitment to learning and healing inspires us every day.

It's #RecognizingResidents Week! At <a href="/OncologyTimes/">Oncology Times</a>, we celebrate the dedication and brilliance of #OncologyResidents who are shaping the future of cancer care. Your commitment to learning and healing inspires us every day.
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Clinician-led advocacy in Minnesota is transforming #cancercare reforms by tackling systemic barriers like prior authorization and #fertilitypreservation, with a focus on rural access, #telehealth expansion, and workforce development. ow.ly/Vzoz50WlMzg

Clinician-led advocacy in Minnesota is transforming #cancercare reforms by tackling systemic barriers like prior authorization and #fertilitypreservation, with a focus on rural access, #telehealth expansion, and workforce development. ow.ly/Vzoz50WlMzg
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Oncology residents! Do you have a story to tell, a perspective to share, or insights that could inspire your peers? Oncology Times wants to hear from you! Read the submission instructions here: ow.ly/UgHk50WujnI #RecognizingResidents AMA

Oncology residents! Do you have a story to tell, a perspective to share, or insights that could inspire your peers? <a href="/OncologyTimes/">Oncology Times</a> wants to hear from you! Read the submission instructions here: ow.ly/UgHk50WujnI #RecognizingResidents <a href="/AmerMedicalAssn/">AMA</a>
Oncology Times (@oncologytimes) 's Twitter Profile Photo

A new study published in #CancerDiscovery reveals that the incidence of several #cancer types is rising among individuals under age 50 in the U.S. Keep reading: ow.ly/Je1A50Wo2f5 #CancerReseach

A new study published in #CancerDiscovery reveals that the incidence of several #cancer types is rising among individuals under age 50 in the U.S. Keep reading: ow.ly/Je1A50Wo2f5 #CancerReseach
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Stay current with evolving strategies! Our #UrothelialCancer Resource Center offers healthcare professionals a library of the latest research and treatment options to keep you informed. ow.ly/6ZpF50WubUs

Stay current with evolving strategies! Our #UrothelialCancer Resource Center offers healthcare professionals a library of the latest research and treatment options to keep you informed. ow.ly/6ZpF50WubUs
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Although #ChatGPT may help answer questions about general information on #coloncancer, such as symptoms, screening, and #prevention, it may not be up to date about #diagnosis and #treatment, according to a new study. Read more here: ow.ly/AZH250WtBv1

Although #ChatGPT may help answer questions about general information on #coloncancer, such as symptoms, screening, and #prevention, it may not be up to date about #diagnosis and #treatment, according to a new study. Read more here: ow.ly/AZH250WtBv1
Oncology Times (@oncologytimes) 's Twitter Profile Photo

The #FDA approved retifanlimab-dlwr with carboplatin and paclitaxel for the first-line treatment of adults with inoperable squamous cell carcinoma of the anal canal. ow.ly/Wruj50Wj1Hl

The #FDA approved retifanlimab-dlwr with carboplatin and paclitaxel for the first-line treatment of adults with inoperable squamous cell carcinoma of the anal canal. ow.ly/Wruj50Wj1Hl
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Circulating tumor DNA (ctDNA) is a key biomarker for detecting molecular residual disease in #ColorectalCancer and other cancers. With new MRD-guided trials and growing data, clinicians are eager to apply this tool in care. Read the article here: ow.ly/hkpZ50WqBeb

Circulating tumor DNA (ctDNA) is a key biomarker for detecting molecular residual disease in #ColorectalCancer and other cancers. With new MRD-guided trials and growing data, clinicians are eager to apply this tool in care. Read the article here: ow.ly/hkpZ50WqBeb
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Medical residents! Do you have a story to tell, a perspective to share, or insights that could inspire your peers? Oncology Times wants to hear from you! Read the submission instructions here: ow.ly/UgHk50WujnI #RecognizingResidents AMA

Medical residents! Do you have a story to tell, a perspective to share, or insights that could inspire your peers? <a href="/OncologyTimes/">Oncology Times</a> wants to hear from you! Read the submission instructions here: ow.ly/UgHk50WujnI #RecognizingResidents <a href="/AmerMedicalAssn/">AMA</a>
Oncology Times (@oncologytimes) 's Twitter Profile Photo

Melanoma, plasma cell neoplasms, cervical, stomach, and bone/joint cancers all had rising incidence in younger populations. Read more about cancer trends here: ow.ly/7T4r50WvsYG #CancerResearch #AYAcancer

Melanoma, plasma cell neoplasms, cervical, stomach, and bone/joint cancers all had rising incidence in younger populations. Read more about cancer trends here: ow.ly/7T4r50WvsYG #CancerResearch #AYAcancer